AGIC Capital acquires Solmetex from Avista
03/19/25, 12:36 PM
Industry
biotechnology
health care
Avista Healthcare Partners has successfully sold Solmetex to AGIC Capital, marking a new chapter for the dental product provider. Avista retains a minority stake in Solmetex to continue supporting its growth. This acquisition aligns AGIC's expertise with Solmetex's vision for innovation in the dental industry.
Company Info
Company info
Founded in 2015, AGIC is a European-Asian fund focused on investments in advanced industrial and healthcare technology companies and has more than US$ 2.2 billion of assets under management. It targets buyout and growth- stage investment in small- and medium-sized companies and employs customized, hands-on approaches to guiding and supporting portfolio companies in developing and executing market penetration plans. AGIC has offices in Munich, London, Hong Kong, Shanghai and Beijing. For more information, please go to www.agic-group.com